Tucson, AZ — University of Arizona Center for Innovation (UACI) is proud to announce that Macula Vision Systems, a pioneer in clinical microscopy, continues to gain momentum as it advances in both national and international stages of the life sciences industry. Macula Vision Systems is based out of UACI at Oro Valley, Arizona – an incubator focused on supporting bioscience startups by providing specialized lab space and tailored business development programming. In recent and upcoming weeks, the company proudly stands out by participating in prestigious programs and pitch competitions, highlighting its groundbreaking advancements in high-throughput imaging and automated interpretation technologies.Continue reading
Author Archive: AZBio
GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
TEMPE, Ariz., Sept. 12, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (“GT MedTech” or the “Company”), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has secured a $35 million venture loan facility, of which $15 million has been initially funded from Horizon Technology Finance Corporation (NASDAQ: HRZN), an affiliate of Monroe Capital.Continue reading
TGen launches Center for Spatial Multi-Omics (COSMO): A Service Center dedicated to transforming biomedical research through spatial biology
PHOENIX, AZ (September 11, 2024) – The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of the Center for Spatial Multi-Omics (COSMO), a service center dedicated to transforming biomedical research through spatial biology. COSMO offers an unparalleled suite of services designed to help scientists visualize and map molecular data at the single-cell level directly within tissues.Continue reading
BIO5 Institute’s Kelle Hyland honored as 2024 AZBio Bioscience Educator of the Year
An integral part of the BIO5 Institute’s KEYS Research Internship program for the past 8 years, Kelle Hyland has been recognized for her extraordinary leadership and dedication by the Arizona Bioindustry Association.Continue reading
AZBioPEERS Video: Preparing for Investor Success
This AZBioPEERS webinar is presented by Richard Kovacik, JD, MBA, Managing Director of the Healthcare Growth Group. The program is designed to equip life science startups with an overview of the most important knowledge and considerations needed to attract and engage investors.Continue reading
Applications Open for ABRC Investigator Grants
The Arizona Biomedical Research Centre (ABRC) of the Arizona Department of Health Services is soliciting grant proposals for RFGA2024-022 Arizona Investigator Grant (AZ IG) or New Investigator Awards (NIA).
This is a two-phased application process. Approximately $10,5000,000 is available for biomedical grant projects over a period of three (3) years.
Multi-year, 1143-patient genetic study identifies unique types of multiple myeloma
TGen-led group confirms high-risk subgroup among cancer patientsContinue reading
Calviri Named Arizona Bioscience Company of the Year
Calviri, a Phoenix, Arizona based company with a mission to end cancer worldwide and to accomplish this mission with affordable products, has been named the Arizona Bioscience Company of the Year and will be celebrated at the 20th annual AZBio Awards on September 18, 2024 at the Phoenix Convention Center.
Calviri was formed in 2017 to end cancer. The team was convinced this could be done as they had discovered a previously unappreciated, yet fundamental, molecular characteristic of all tumors that distinguishes them from healthy host cells. Calviri also invented chip technologies that would leverage their discovery to uniquely battle cancer. After years of research and many patents, Calviri is now developing multi-cancer tests to accurately detect stage 1 disease, which can be treated with its early-stage therapeutic vaccines. Calviri’s research has also shown them the path to the seeming impossible: a preventative cancer vaccine. All rooted in the power of Calviri’s molecular discoveries and semiconductor inventions, the company is now ready to globally provide diagnostics and vaccines that will end cancer. Full stop.
New Short Term Shared Lab Space Available from CEI LabForce in Phoenix
Thanks to generous support from the Flinn Foundation and the Arizona Department of Health Services, CEI LabForce is able to offer temporary shared lab space at their facility at 850 PBC in downtown Phoenix. Designed to support the needs of life science innovators at the proof-of-concept stage, the lab provides access to cutting-edge equipment and resources, enabling researchers and startups to accelerate their projects without the burden of substantial upfront investments.Continue reading